Psilocybin trials show poorer control group outcomes compared to SSRIs and esketamine, potentially inflating perceived efficacy due to expectancy bias and functional unblinding. Control group response ...
IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.
Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with radioligand intensification despite early on-treatment score fluctuations. FACT-P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results